Low-dose intravenous ketamine versus intravenous ketorolac in pain control in patients with acute renal colic in an emergency setting: a double-blind randomized clinical trial
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: This study was conducted to compare the effectiveness of low-dose ketamine versus ketorolac in pain control in patients with acute renal colic presenting to the emergency department (ED). Methods: This is a double-blind randomized clinical trial. The initial pain severity was assessed using the numerical rating scale (NRS). Then, ketamine or ketorolac was administered intravenously at a dose of 0.6 mg/kg and 30 mg respectively. The pain severity and adverse drug reactions were recorded 5, 15, 30, 60, and 120 min thereafter. Results: The data of 62 subjects in the ketamine group and 64 patients in the ketorolac group were analyzed. The mean age of the patients was 34.2 ± 9.9 and 37.9 ± 10.6 years in the ketamine and ketorolac group, respectively. There was no significant difference in the mean NRS scores at each time point, except for the 5 min, between the two groups. Despite a marked decrease in pain severity in the ketamine group from drug administration at the 5 min, a slight increase in pain was observed from the 5 min to the 15 min. The rate of adverse drug reactions, including dizziness (P = 0.001), agitation (P = 0.002), increased systolic blood pressure (＞ 140 mmHg), and diastolic blood pressure (＞ 90 mmHg) was higher in the ketamine group. Conclusions: Low dose ketamine is as effective as ketorolac in pain management in patients with renal colic presenting to the ED. However, it is associated with a higher rate of adverse drug reactions.
Abstract
Background: This study was conducted to compare the effectiveness of low-dose ketamine versus ketorolac in pain control in patients with acute renal colic presenting to the emergency department (ED). Methods: This is a double-blind randomized clinical trial. The initial pain severity was assessed using the numerical rating scale (NRS). Then, ketamine or ketorolac was administered intravenously at a dose of 0.6 mg/kg and 30 mg respectively. The pain severity and adverse drug reactions were recorded 5, 15, 30, 60, and 120 min thereafter. Results: The data of 62 subjects in the ketamine group and 64 patients in the ketorolac group were analyzed. The mean age of the patients was 34.2 ± 9.9 and 37.9 ± 10.6 years in the ketamine and ketorolac group, respectively. There was no significant difference in the mean NRS scores at each time point, except for the 5 min, between the two groups. Despite a marked decrease in pain severity in the ketamine group from drug administration at the 5 min, a slight increase in pain was observed from the 5 min to the 15 min. The rate of adverse drug reactions, including dizziness (P = 0.001), agitation (P = 0.002), increased systolic blood pressure (＞ 140 mmHg), and diastolic blood pressure (＞ 90 mmHg) was higher in the ketamine group. Conclusions: Low dose ketamine is as effective as ketorolac in pain management in patients with renal colic presenting to the ED. However, it is associated with a higher rate of adverse drug reactions.
참고문헌 (44)
- Teichman JM, "Clinical practice : acute renal colic from ureteral calculus", N Engl J Med, 350, pp.684~693 (2004)
- Romero V, "Kidney stones : a global picture of prevalence, incidence, and associated risk factors", Rev Urol, 12, pp.e86~e96 (2010)
- Brown J, "Diagnostic and treatment patterns for renal colic in US emergency departments", Int Urol Nephrol, 38, pp.87~92 (2006)
- Zabihi N, "Dealing with the pain of renal colic", Lancet, 358, pp.437~438 (2001)
- Engeler DS, "The ideal analgesic treatment for acute renal colic : theory and practice", Scand J Urol Nephrol, 42, pp.137~142 (2008)
- Bounes V, "Treatment of acute renal colic in Us and French EDs : simulated cases and real cases in acute pain management", Am J Emerg Med, 34, pp.1955~1958 (2016)
- Shin MT, "Pain severity in renal colic : a retrospective evaluation of initial visits in patients at a medical center", Int Surg J, 3, pp.480~483 (2016)
- Janati M, "Educational intervention effect on pain management quality in emergency department; a clinical audit", Adv J Emerg Med, 2, pp.e16~ (2018)
- Miller NL, "Management of kidney stones", BMJ, 334, pp.468~472 (2007)
- Knoedler JJ, "Non-steroidal anti-inflammatory drugs for renal colic", Lancet, 387, pp.1971~1972 (2016)
- Bultitude M, "Management of renal colic", BMJ, 345, pp.e5499~ (2012)
- Benyamin R, "Opioid complications and side effects", Pain Physician, 11(2 Suppl), pp.S105~S120 (2008)
- Baratloo A, "Efficacy measurement of ketorolac in reducing the severity of headache", J Emerg Pract Trauma, 2, pp.21~24 (2016)
- Alimohammadi H, "Effects of pain relief on arterial blood o2 saturation", Trauma Mon, 19, pp.e14034~ (2014)
- Edwards JM, "Renal colic patient pain management in the emergency department", Ann Emerg Med, 44(4 Suppl), pp.S58~ (2004)
- Abdolrazaghnejad A, "Pain management in the emergency department : a review article on options and methods", Adv J Emerg Med, 2, pp.e45~ (2018)
- Tramèr MR, "Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain : a qualitative systematic review", Acta Anaesthesiol Scand, 42, pp.71~79 (1998)
- Manthey DE, "Tintinalli's emergency medicine: a comprehensive study guide", pp.609~613 (2016), McGraw-Hill
- Jackson J, "Retrospective review of acute renal colic management in the emergency department and review of guidelines", Urol Pract, 5, pp.113~119 (2018)
- Arhami Dolatabadi A, "Intranasal desmopressin compared with intravenous ketorolac for pain management of patients with renal colic referring to the emergency department : a randomized clinical trial", Anesth Pain Med, 7, pp.e43595~ (2017)
- Holdgate A, "Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic", BMJ, 328, pp.1401~ (2004)
- Svenson JE, "Ketamine for prehospital use : new look at an old drug", Am J Emerg Med, 25, pp.977~980 (2007)
- Morgan CJ, "Independent Scientific Committee on Drugs. Ketamine use: a review", Addiction, 107, pp.27~38 (2012)
- Persson J, "Ketamine in pain management", CNS Neurosci Ther, 19, pp.396~402 (2013)
- Mohammadshahi A, "Intranasal ketamine administration for narcotic dose decrement in patients suffering from acute limb trauma in emergency department: a double-blind randomized placebocontrolled trial", Adv J Emerg Med, 2, pp.e30~ (2018)
- Pasero C, "Pain control : ketamine : low doses may provide relief for some painful conditions", Am J Nurs, 105, pp.60~64 (2005)
- Weisz K, "Adverse events during a randomized trial of ketamine versus co-administration of ketamine and propofol for procedural sedation in a pediatric emergency department", J Emerg Med, 53, pp.1~9 (2017)
- Treston G, "What is the nature of the emergence phenomenon when using intravenous or intramuscular ketamine for paediatric procedural sedation", Emerg Med Australas, 21, pp.315~322 (2009)
- Huge V, "Effects of low-dose intranasal(S)-ketamine in patients with neuropathic pain", Eur J Pain, 14, pp.387~394 (2010)
- Bilgen S, "Effect of three different doses of ketamine prior to general anaesthesia on postoperative pain following Caesarean delivery : a prospective randomized study", Minerva Anestesiol, 78, pp.442~449 (2012)
- Loeser JD, "Pain : an overview", Lancet, 353, pp.1607~1609 (1999)
- Sadove MS, "Analgesic effects of ketamine administered in subdissociative doses", Anesth Analg, 50, pp.452~457 (1971)
- Visser E, "The role of ketamine in pain management", Biomed Pharmacother, 60, pp.341~348 (2006)
- Galinski M, "Management of severe acute pain in emergency settings : ketamine reduces morphine consumption", Am J Emerg Med, 25, pp.385~390 (2007)
- Bespalov AY, "Opioid-NMDA receptor interactions may clarify conditioned(associative)components of opioid analgesic tolerance", Neurosci Biobehav Rev, 25, pp.343~353 (2001)
- Farnia MR, "Comparison of intranasal ketamine versus IV morphine in reducing pain in patients with renal colic", Am J Emerg Med, 35, pp.434~437 (2017)
- Vosoughin M, "Intravenous ketamine compared with diclofenac suppository in suppressing acute postoperative pain in women undergoing gynecologic laparoscopy", J Anesth, 26, pp.732~737 (2012)
- Assouline B, "Benefit and harm of adding ketamine to an opioid in a patient-controlled analgesia device for the control of postoperative pain : systematic review and meta-analyses of randomized controlled trials with trial sequential analyses", Pain, 157, pp.2854~2864 (2016)
- Holinstat M, "Normal platelet function", Cancer Metastasis Rev, 36, pp.195~198 (2017)
- Tawfic QA, "A review of the use of ketamine in pain management", J Opioid Manag, 9, pp.379~388 (2013)
- Andolfatto G, "Intranasal ketamine for analgesia in the emergency department : a prospective observational series", Acad Emerg Med, 20, pp.1050~1054 (2013)
- Wedmore IS, "Pain management in the wilderness and operational setting", Emerg Med Clin North Am, 23, pp.585~601 (2005)[DOI]
- Allen CA, "Ketamine for pain management-side effects & potential adverse events", Pain Manag Nurs, 18, pp.372~377 (2017)
- Ghate G, "Systematic review of the use of low-dose ketamine for analgesia in the emergency department", CJEM, 20, pp.36~45 (2018)